Perspectives on Medical Reimbursement By JR Associates In recent months, the coronavirus pandemic (Covid-19) has dramatically disrupted businesses around the world. Arguably, healthcare has been more profoundly affected than any other industry. But even as attention remains focused on virus containment and treatment, medical technology companies must prepare for the long-term. “What next?” is…
Perspectives on Medical Reimbursement By JR Associates Over the years, our consultants have developed strong, productive working relationships with many influential medical and biotech industry associations, including the Medical Device Manufacturers Association (MDMA). One of the highlights of MDMA’s annual events calendar is its Coverage, Reimbursement and Health Policy Conference, where our leaders have participated as featured…
Perspectives on Medical Reimbursement By JR Associates Through the years, our consultants have become popular as featured speakers at a variety of prestigious medical technology forums. But the highlight of our annual events calendar is always the MDMA Coverage, Reimbursement & Health Policy Conference. It is deeply rewarding to connect directly with medical device professionals and discuss critical…
Perspectives on Medical Reimbursement By JR Associates Coverage. Coding. Payment. These three factors deeply influence reimbursement for every new medical technology product. But there are no “cookie cutter” solutions. Because the reimbursement landscape is so complex and time consuming, it’s smart to start preparing for reimbursement as early as possible in the business planning and product development process. But…
Perspectives on Medical Reimbursement By JR Associates When medical technology companies develop reimbursement strategies for the U.S. market, it’s a smart business move to look beyond this country’s borders. That’s the advice JR Associates VP of Global Health Policy, Jo Ellen Slurzberg shared in a recent interview with Medical Device Daily. Jo Ellen acknowledged that planning…
Perspectives on Medical Reimbursement Issues By JR Associates Whitepaper: Impact of ICD-10 on Coding and Reimbursement for Cardiac Rhythm Management Procedures Authors: • Beth Bontemps, MSN, RN, NP, CCS Senior Consultant, JR Associates, Inc. • Rayellen Gilles, Customer Experience, Wolters Kluwer Law & Business Summary: By October 1, 2013, all U.S. healthcare providers are required to…
Perspectives on Medical Reimbursement By JR Associates The path to advancements in disease detection and treatment is notoriously complex, circuitous and costly. However, even after FDA approval, there are no guarantees of reimbursement through CMS coverage. This is an essential lesson in the case of Eli Lilly’s Amyvid PET scan imaging agent, which is used…
New Consultant Position Solidifies Reimbursement Consulting Firm’s Commitment to International Clients Los Angeles, CA — June 30, 2011 — JR Associates, reimbursement advisors to some of the world’s most innovative medical device companies, today announced that Jo Ellen Slurzberg has joined the firm as Vice President, Global Health Policy. With decades of extraordinary reimbursement accomplishments…
